热门资讯> 正文
Spruce Biosciences恢复纳斯达克交易;股价上涨逾40%
2025-09-15 19:42
- Spruce Biosciences (OTC:SPRB) will resume trading on Nasdaq, September 15, 2025.
- The company focuses on developing therapies for neurological disorders with high unmet medical need.
- SPRB shares up 40.6% premarket on Monday.
- Source: Press release
More on Spruce Biosciences
- Seeking Alpha’s Quant Rating on Spruce Biosciences
- Historical earnings data for Spruce Biosciences
- Financial information for Spruce Biosciences
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。